Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
Clinical Biochemistry | |||
Reference | AS3098 | Version | 4 |
Created | August 2017 | SCQF Level | SCQF 9 |
Approved | September 2004 | SCQF Points | 15 |
Amended | August 2017 | ECTS Points | 7.5 |
Aims of Module | |||
---|---|---|---|
To provide students with the ability to apply the principles of clinical biochemistry to the diagnosis, treatment and monitoring of disease. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Discuss the factors which can lead to the development of cardiovascular gastrointestinal, renal, endocrine and liver disorders and explain how these can be diagnosed and treated. |
2 | Define how pregnancy can be confirmed and how maternal and foetal health can be monitored. |
3 | Evaluate the principles of biochemical investigations used in the diagnosis, treatment and management of inborn errors of metabolism and/or hereditary malignant disease. |
4 | Discuss the principles and uses of therapeutic drug monitoring and how substances of abuse can be investigated. |
5 | Discuss the range and applications of near-patient tests and non-invasive techniques. |
Indicative Module Content |
---|
Inborn errors of metabolism and hereditary disease: genetic and biochemical basis of inherited disease, clinical consequences of common inherited diseases, management of inherited disease, mass screening programmes and laboratory investigations. Therapeutic Drug Monitoring (TDM) and toxicology: pharmacokinetic principles as applied to TDM, therapeutic benefits and adverse side effects, drugs of abuse screening programmes, pre-employment and industrial health screening, legal implications, laboratory investigations in emergency toxicology and forensic science. Clinical Endocrinology: diagnosis of selected endocrine disorders, thyroid function tests. Clinical chemistry of the kidney and related disorders: role of kidney in homeostasis of nitrogen, renal function tests, creatinine, gout and aminoacidurias. Cardiovascular disease: platelet functions, thromboses and atherosclerosis. Near-patient testing and selected non-invasive techniques. Liver disease: liver function tests, jaundice. Gastroenterology: gastric and duodenal function tests, malabsorption syndromes. Clinical chemistry of pregnancy and lactation: pregnancy tests, prenatal diagnosis of birth defects, hormonal monitoring of foetal and maternal health, postnatal screening tests. |
Module Delivery |
---|
This is a lecture and case study oriented course supplemented with directed reading, seminars from visiting speakers and tutorial sessions. |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | 30 | N/A |
Non-Contact Hours | 120 | N/A |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | 150 | N/A |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Examination | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3, 4 |
Description: | A closed book examination consisting of two sections: Section A will be one of three pre-seen case studies; Section B will consist of essay questions. | ||||
Component 2 | |||||
Type: | Coursework | Weighting: | 0% | Outcomes Assessed: | 5 |
Description: | The coursework will consist of an essay in which the student will show understanding of near-patient testing and non-invasive techniques giving selected examples. It will be marked as either a pass or fail. |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
This module is assessed using the 2 components of assessment as detailed in the Assessment Plan. To pass this module, candidates must achieve a grade D or better. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | Final aggregate mark of 70% or greater and a PASS in C2. |
B | Final aggregate mark of between 60-69% and a PASS in C2. |
C | Final aggregate mark of between 50-59% and a PASS in C2. |
D | Final aggregate mark of between 40-49% and a PASS in C2. |
E | MARGINAL FAIL. Final aggregate mark of between 35-39% and a PASS in C2. |
F | FAIL. A mark of less than 35% in C1 and/or a FAIL in C2. |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | In addition to SCQF 9 entry requirements, students should be familiar with human biochemistry and human physiology. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
1 | AHMED, N. Clinical Biochemistry. Current Edition. Oxford University Press. |
2 | BURTIS, C.A. AND ASHWOOD, E.R. Tietz: Fundamentals of Clinical Chemistry. Current Edition. Saunders. |
3 | LUXTON, R. Clinical Biochemistry. Current Edition. Scion Publishing Ltd. |
4 | PRICE, C.P., St JOHN, A. AND HICKS, J.M. Point of Care Testing. Current Edition. American Association of Clinical Chemistry. |
5 | MOORE, G., KNIGHT, G. and BLANN, A. Haematology. Current Edition. Oxford University Press. |
6 | KNIGHT, R. Transfusion and Transplantation Science. Current Edition. Oxford University Press. |
7 | OVERFIELD, J., DAWSON, M. AND HAMER, D. Transfusion Science. Current Edition. Scion Publishing Ltd. |
8 | HALL, A., SCOTT, C. AND BUCKLAN, M. Clinical Immunology. Current Edition. Oxford University Press. |